尼日利亚晚期HIV疾病患者中组织胞浆菌病患病率
在尼日利亚5个地缘政治区10个中心开展横断面研究,招募988例晚期HIV疾病患者,采用组织胞浆菌酶免疫法检测尿抗原,76例(7.7%)抗原阳性;抗原阳性者CD4计数显著更低(p=0.03),9例(11.8%)合并结核,50/76(65.8%)曾接受抗逆转录病毒治疗。
要点
- 晚期HIV疾病患者中组织胞浆菌抗原阳性率为7.7%(76/988)。
- 抗原阳性者CD4计数显著低于抗原阴性者(p=0.03)。
- 作者认为组织胞浆菌抗原检测应纳入晚期HIV疾病照护包。
核心结论
- 尼日利亚晚期HIV疾病患者中组织胞浆菌病常为隐匿性疾病,作者认为组织胞浆菌抗原检测应纳入晚期HIV疾病照护包。
研究设计与样本
- 横断面研究,在尼日利亚6个地缘政治区中5个区的10个中心开展,共招募988例参与者。
- 纳入标准为尿标本CD4细胞计数<200 cells/mm3或世界卫生组织3期或4期疾病,且具有>2项播散性组织胞浆菌病临床特征。
- 采用组织胞浆菌酶免疫法检测组织胞浆菌抗原。
主要发现
- 988例参与者中76例(7.7%)组织胞浆菌抗原阳性。
- 76例抗原阳性参与者CD4计数显著更低(p=0.03)。
- 76例抗原阳性参与者中9例(11.8%)合并结核感染。
- 抗原阳性参与者中50/76(65.8%)曾接受抗逆转录病毒治疗(p=0.015),26/76(34.2%)未接受过。
临床怎么用
- 作者认为组织胞浆菌抗原检测应纳入晚期HIV疾病照护包。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We sought to determine the prevalence of probable disseminated histoplasmosis among advanced HIV disease (AHD) patients in Nigeria. We conducted a cross-sectional study in 10 sites across 5 of 6 geopolitical zones in Nigeria. We identified patients with urinary samples containing CD4 cell counts <200 cells/mm3 or World Health Organization stage 3 or 4 disease who also had >2 clinical features of disseminated histoplasmosis, and we tested them for Histoplasma antigen using a Histoplasma enzyme immune assay. Of 988 participants we recruited, 76 (7.7%) were antigen-positive. The 76 Histoplasma antigen-positive participants had significantly lower (p = 0.03) CD4 counts; 9 (11.8%) were also co-infected with tuberculosis. Most antigen-positive participants (50/76; 65.8%; p = 0.015) had previously received antiretroviral treatment; 26/76 (34.2%) had not. Because histoplasmosis is often a hidden disease among AHD patients in Nigeria, Histoplasma antigen testing should be required in the AHD package of care.
引用
- Oladele RO, Osaigbovo II, Akanmu AS, et al. Prevalence of Histoplasmosis among Persons with Advanced HIV Disease, Nigeria. Emerg Infect Dis. 2022. PMID: 36286009. doi:10.3201/eid2811.220542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。